Tear trough rejuvenation: A safety evaluation of the treatment by a semi-cross-linked hyaluronic acid filler
| Autor: | Olivier Galatoire, Marouen Berguiga |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty medicine.drug_class Injections Subcutaneous Mesotherapy Cosmetic Techniques 030230 surgery 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Patient satisfaction Hyaluronidase Dermal Fillers Hyaluronic acid Deformity medicine Humans Rejuvenation Prospective Studies Hyaluronic Acid Adverse effect Viscosupplements Injection Procedure Local anesthetic business.industry Lacrimal Apparatus Middle Aged Skin Aging Surgery Ophthalmology chemistry Tolerability Patient Satisfaction 030221 ophthalmology & optometry Female medicine.symptom business medicine.drug |
| Zdroj: | Orbit. 36:22-26 |
| ISSN: | 1744-5108 0167-6830 |
| Popis: | The aim of this study is to describe the experience of 33 physicians, dermatologists and surgeons, with the use of a semi-cross-linked hyaluronic acid (HA) gel as a tear trough deformity filler within one month following injection, and to assess patient satisfaction with the procedure. This study is a case series conducted between February 2012 and December 2012 with the use of semi-cross-linked HA to correct tear trough deformity. The filler was administered in the preperiosteal tissues. The study involved case note review and a patient satisfaction survey. A total of 302 eyes of 151 patients were treated by 33 physicians, with a mean follow-up of 3 weeks. Patients were mainly female (86%), and middle-aged (mean age 48 years old). The gel was placed preperiosteally, deep to the orbicularis, anterior to the inferior orbital rim, with a mean volume of 0.48 ml per eye to achieve correction. The injection procedure was performed without local anesthetic for 79% of the patients. No serious adverse event was recorded. Side effects reported by investigators immediately after injection included bruising (11%), swelling (12%), and redness (inflammation 12%). Very few transitional blue discolorations (2.6%) were observed. No patient required dissolution with hyaluronidase. According to our satisfaction survey, all patients had cosmetic improvement. Most patients (97%) described marked or moderate satisfaction with the treatment. At one month, 18% requested additional hyaluronic acid gel for a touch-up injection. This case series confirms the effective use of a semi-cross-linked HA gel in tear trough rejuvenation. It has excellent patient tolerability, minimal complications, and excellent patient satisfaction. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |